Hutch News

Hutch News

Stories tagged 'Lymphoma'

Good News at Fred Hutch

Celebrating faculty and staff achievements

Sept. 14, 2017

An immunotherapy technology developed by Dr. Brian Till with Dr. Oliver Press at Fred Hutchinson Cancer Research Center has been licensed by Mustang Bio Inc., a subsidiary of the biopharmaceutical company Fortress Biotech Inc. The exclusive, worldwide license, announced Sept. 14 by Mustang Bio, will allow a new type of CAR (chimeric antigen receptor) T-cell therapy to be tested in a clinical trial as a treatment for B-cell non-Hodgkin lymphomas. The novel immunotherapy targets CD20, a protein marker on cancer cells in lymphoma.

View story >


New integrated research center launches

Dr. Denise Galloway heads new collaborative center to study prevention and treatment of cancers linked to infectious agents

Aug. 10, 2017 | By Sabrina Richards / Fred Hutch News Service

Dr. Denise Galloway heads new collaborative center to research prevention and treatment of infection-related cancers

View story >


‘He transformed my life’: A cancer doctor’s work comes full circle

The impact of Dr. Oliver Press, pioneering researcher, beloved physician and influential mentor

May 1, 2017 | by Susan Keown / Fred Hutch News Service

Once a boy with an obsession for animals, he's now a doctor and researcher known around the world for his dedication to saving patients' lives. (And he's still obsessed with animals.) Meet Dr. Oliver Press.

View story >


Bezos family gives $35 million to Fred Hutch

‘What we are really giving is the gift of time’; funds will be invested in more world-class faculty to speed cures for cancer patients

March 30, 2017 | By Linda Dahlstrom / Fred Hutch News Service

The single, largest gift to Fred Hutchinson Cancer Research Center will be invested in hiring more world-class faculty to speed cures for cancer patients, said President and Director Dr. Gary Gilliland.

View story >


‘A place where miracles happen’: Opening of Bezos Family Immunotherapy Clinic highlights patient-focused science

Research symposium and ribbon cutting celebrates first-of-its-kind facility for experimental immunotherapies

Dec. 16, 2016 | By Susan Keown / Fred Hutch News Service

Lymphoma survivor Stephanie Florence said she wouldn't be alive if not for the science done at Fred Hutchinson Cancer Research Center. This week, she cut the ribbon at the grand opening of the Bezos Family Immunotherapy Clinic, which will make it possible for twice as many patients like Florence to receive treatment.

View story >


'A place where miracles happen': Opening of Bezos Family Immunotherapy Clinic highlights patient-focused science

Research symposium and ribbon cutting celebrates first-of-its-kind facility for experimental immunotherapies

Dec. 13, 2016 | by Susan Keown / Fred Hutch News Service

The new Bezos Family Immunotherapy Clinic is dedicated to providing immunotherapies for cancer patients in clinical trials and enables 'intensive research' to move the immunotherapy field forward.

View story >



GIVE NOW &
SAVE LIVES

Support our quest for cures

Story Archive


Publications

Hutch Magazine
Our quarterly magazine

Annual Report
Fiscal year highlights

Science Spotlight
Monthly review of Center-authored papers



Fred Hutch News

        Get updates via email.